Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema

Summary

The purpose of this study was to demonstrate that the change of best corrected visual acuity (BCVA) was comparable in patients treated with ranibizumab at the discretion of the investigator vs. treatment according to a standard of care scheme (pro re nata, as needed).

Timeline

Start

2015-02-23

Primary completion

2017-06-08

Completion

2017-06-08

Drugs

Indications